Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 10,876
Sort by:

Global Sedatives Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

US$ 3,950.00

The report on global sedatives market evaluates the growth trends of the industry through historical study ... and probable opportunities of the market. The report also covers the complete competitive landscape of the worldwide market with company profiles of key ...

March 2020 95 pages

Global Antibody Drug Conjugates Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Global Market Forecasts to 2023

US$ 2,000.00

... Global Antibody Drug Conjugates Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Global Market Forecasts to 2023”, the Global Antibody Drug Conjugates ... and advances in linking technologies, for the Global Antibody Drug Conjugates Market. Furthermore, the report also gives ...

March 2020 110 pages

Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026

US$ 7,000.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. 'Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026' Report Highlights:...

March 2020 2400 pages

2020 Alcohol Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Alcohol Addiction pipeline report presents a comprehensive overview of the research and development of Alcohol Addiction drug candidates. It presents drugs in development that could potential...

February 2020 133 pages

2020 Anesthetic Effect Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Anesthetic Effect pipeline report presents a comprehensive overview of the research and development of Anesthetic Effect drug candidates. It presents drugs in development that could potential...

February 2020 88 pages

2020 Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Attention Deficit Hyperactivity Disorder (ADHD) pipeline report presents a comprehensive overview of the research and development of Attention Deficit Hyperactivity Disorder (ADHD) drug candi...

February 2020 155 pages

2020 Autism spectrum disorders (ASD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Autism spectrum disorders (ASD) pipeline report presents a comprehensive overview of the research and development of Autism spectrum disorders (ASD) drug candidates. It presents drugs in deve...

February 2020 127 pages

2020 Batten Disease Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Batten Disease pipeline report presents a comprehensive overview of the research and development of Batten Disease drug candidates. It presents drugs in development that could potentially rea...

February 2020 82 pages

2020 Binge Eating Disorder Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Binge Eating Disorder pipeline report presents a comprehensive overview of the research and development of Binge Eating Disorder drug candidates. It presents drugs in development that could p...

February 2020 55 pages

2020 Canavan Disease Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Canavan Disease pipeline report presents a comprehensive overview of the research and development of Canavan Disease drug candidates. It presents drugs in development that could potentially r...

February 2020 31 pages

2020 Cancer Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Cancer Pain pipeline report presents a comprehensive overview of the research and development of Cancer Pain drug candidates. It presents drugs in development that could potentially reach the...

February 2020 132 pages

2020 Cerebral Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Cerebral Palsy pipeline report presents a comprehensive overview of the research and development of Cerebral Palsy drug candidates. It presents drugs in development that could potentially rea...

February 2020 46 pages

2020 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline report presents a comprehensive overview of the research and development of Chronic Inflammatory Demyelinating Polyneuropathy...

February 2020 51 pages

2020 Cluster Headache Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Cluster Headache pipeline report presents a comprehensive overview of the research and development of Cluster Headache drug candidates. It presents drugs in development that could potentially...

February 2020 42 pages

2020 Cognitive Impairment Associated With Schizophrenia (CIAS) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline report presents a comprehensive overview of the research and development of Cognitive Impairment Associated With Schizophren...

February 2020 87 pages

2020 Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) pipeline report presents a comprehensive overview of the research and development of Complex Regional Pain Syndrome (Reflex Sympa...

February 2020 51 pages

2020 Dental Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Dental Pain pipeline report presents a comprehensive overview of the research and development of Dental Pain drug candidates. It presents drugs in development that could potentially reach the...

February 2020 36 pages

2020 Drug Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Drug Addiction pipeline report presents a comprehensive overview of the research and development of Drug Addiction drug candidates. It presents drugs in development that could potentially rea...

February 2020 169 pages

2020 Encephalitis Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Encephalitis pipeline report presents a comprehensive overview of the research and development of Encephalitis drug candidates. It presents drugs in development that could potentially reach t...

February 2020 47 pages

2020 Encephalomyelitis Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Encephalomyelitis pipeline report presents a comprehensive overview of the research and development of Encephalomyelitis drug candidates. It presents drugs in development that could potential...

February 2020 51 pages

2020 Fatigue Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Fatigue pipeline report presents a comprehensive overview of the research and development of Fatigue drug candidates. It presents drugs in development that could potentially reach the market...

February 2020 42 pages

2020 Fibromyalgia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Fibromyalgia pipeline report presents a comprehensive overview of the research and development of Fibromyalgia drug candidates. It presents drugs in development that could potentially reach t...

February 2020 76 pages

2020 Friedreich Ataxia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Friedreich Ataxia pipeline report presents a comprehensive overview of the research and development of Friedreich Ataxia drug candidates. It presents drugs in development that could potential...

February 2020 102 pages

2020 Globoid Cell Leukodystrophy (Krabbe Disease) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Globoid Cell Leukodystrophy (Krabbe Disease) pipeline report presents a comprehensive overview of the research and development of Globoid Cell Leukodystrophy (Krabbe Disease) drug candidates....

February 2020 52 pages

2020 Guillain-Barre Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Guillain-Barre Syndrome pipeline report presents a comprehensive overview of the research and development of Guillain-Barre Syndrome drug candidates. It presents drugs in development that cou...

February 2020 46 pages

2020 Hyperalgesia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Hyperalgesia pipeline report presents a comprehensive overview of the research and development of Hyperalgesia drug candidates. It presents drugs in development that could potentially reach t...

February 2020 34 pages

2020 Insomnia (Sleep Deprivation) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Insomnia (Sleep Deprivation) pipeline report presents a comprehensive overview of the research and development of Insomnia (Sleep Deprivation) drug candidates. It presents drugs in developmen...

February 2020 107 pages

2020 Interstitial Cystitis (Painful Bladder Syndrome) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Interstitial Cystitis (Painful Bladder Syndrome) pipeline report presents a comprehensive overview of the research and development of Interstitial Cystitis (Painful Bladder Syndrome) drug can...

February 2020 71 pages

2020 Low Back Pain Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Low Back Pain pipeline report presents a comprehensive overview of the research and development of Low Back Pain drug candidates. It presents drugs in development that could potentially reach...

February 2020 104 pages

2020 Metachromatic Leukodystrophy (MLD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Metachromatic Leukodystrophy (MLD) pipeline report presents a comprehensive overview of the research and development of Metachromatic Leukodystrophy (MLD) drug candidates. It presents drugs i...

February 2020 54 pages

2020 Mild Cognitive Impairment (MCI) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Mild Cognitive Impairment (MCI) pipeline report presents a comprehensive overview of the research and development of Mild Cognitive Impairment (MCI) drug candidates. It presents drugs in deve...

February 2020 94 pages

2020 Multiple System Atrophy (MSA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Multiple System Atrophy (MSA) pipeline report presents a comprehensive overview of the research and development of Multiple System Atrophy (MSA) drug candidates. It presents drugs in developm...

February 2020 78 pages

2020 Narcolepsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Narcolepsy pipeline report presents a comprehensive overview of the research and development of Narcolepsy drug candidates. It presents drugs in development that could potentially reach the m...

February 2020 82 pages

2020 Neuromyelitis Optica (Devic's Syndrome) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Neuromyelitis Optica (Devic's Syndrome) pipeline report presents a comprehensive overview of the research and development of Neuromyelitis Optica (Devic's Syndrome) drug candidates. It presen...

February 2020 112 pages

2020 Nicotine Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Nicotine Addiction pipeline report presents a comprehensive overview of the research and development of Nicotine Addiction drug candidates. It presents drugs in development that could potenti...

February 2020 78 pages

2020 Obsessive Compulsive Disorder (OCD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Obsessive Compulsive Disorder (OCD) pipeline report presents a comprehensive overview of the research and development of Obsessive Compulsive Disorder (OCD) drug candidates. It presents drugs...

February 2020 51 pages

2020 Opioid Addiction Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Opioid Addiction pipeline report presents a comprehensive overview of the research and development of Opioid Addiction drug candidates. It presents drugs in development that could potentially...

February 2020 132 pages

2020 Post-Traumatic Stress Disorder (PTSD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Post-Traumatic Stress Disorder (PTSD) pipeline report presents a comprehensive overview of the research and development of Post-Traumatic Stress Disorder (PTSD) drug candidates. It presents d...

February 2020 133 pages

2020 Progressive Supranuclear Palsy Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Progressive Supranuclear Palsy pipeline report presents a comprehensive overview of the research and development of Progressive Supranuclear Palsy drug candidates. It presents drugs in develo...

February 2020 82 pages

2020 Restless Legs Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Restless Legs Syndrome pipeline report presents a comprehensive overview of the research and development of Restless Legs Syndrome drug candidates. It presents drugs in development that could...

February 2020 56 pages

2020 Rett Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Rett Syndrome pipeline report presents a comprehensive overview of the research and development of Rett Syndrome drug candidates. It presents drugs in development that could potentially reach...

February 2020 106 pages

2020 Sedation Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Sedation pipeline report presents a comprehensive overview of the research and development of Sedation drug candidates. It presents drugs in development that could potentially reach the marke...

February 2020 46 pages

2020 Spinal Muscular Atrophy (SMA) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Spinal Muscular Atrophy (SMA) pipeline report presents a comprehensive overview of the research and development of Spinal Muscular Atrophy (SMA) drug candidates. It presents drugs in developm...

February 2020 116 pages

2020 Tourette Syndrome Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Tourette Syndrome pipeline report presents a comprehensive overview of the research and development of Tourette Syndrome drug candidates. It presents drugs in development that could potential...

February 2020 56 pages

2020 Trigeminal Neuralgia Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs

US$ 1,799.00

The 2020 Trigeminal Neuralgia pipeline report presents a comprehensive overview of the research and development of Trigeminal Neuralgia drug candidates. It presents drugs in development that could pot...

February 2020 51 pages

Global Androgen Deprivation Therapy (ADT) Market Size study, by Drug Class (Antiandrogens, LHRH Agonists, LHRH Antagonist, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2019-2026

US$ 3,750.00

Global Androgen Deprivation Therapy (ADT) Market is valued approximately at USD XX billion in 2018 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-...

February 2020 200 pages

Global Cell-based Assay Market Size study, by Product (Consumables, Instruments, Services), by Application (Drug Discovery, Basic Research, Other Applications), by End-User (Pharmaceutical & Biotechnological Companies, Academic & Government Institutes, Contract Research Organizations) and Regional Forecasts 2019-2026

US$ 3,750.00

Global Cell-based Assay Market is valued approximately at USD 12.97 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2019-2026. Cell-bas...

February 2020 200 pages

Global Prebiotics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

US$ 3,950.00

Value Market Research’s latest report on the Global Prebiotics Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecas...

February 2020 105 pages

Prevymis (letermovir) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Prevymis (letermovir) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the p...

February 2020 50 pages

Promacta/Revolade (eltrombopag) - Drug Insight and Market Forecast - 2030

US$ 2,750.00

This report can be delivered to the clients within 48 Hours OVERVIEW “Promacta/Revolade (eltrombopag) - Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insight...

February 2020 50 pages

Filters

Search

Publishers

1
450
353
174
29
4
837
409
36
27
2,279
77
19
16
2
21
1
16
1
9
9
2,264
5
4
31
6
142
1
17
15
248
651
91
1
373
26
34
724
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
106
27
19
4
7
3
324
15
1
23
86
24
28
44
296
17
18
2

Regions

131
40
38
37
37
35
32
23
13
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
91
12
354
30
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
39
6
4
3
3
3
1
1
3
7
9,529

Price

—

Date

—

Pages

—

Offers

9
1